|
|
||||||||
-subunit mRNA
2 Canadian Institutes of Health Research Group in Lung Development, Research Institute, Hospital for Sick Children, and Departments of 1 Paediatrics and 3 Physiology, University of Toronto, Ontario M5G 1X8, Canada
| |
ABSTRACT |
|---|
|
|
|---|
The rat amiloride-sensitive
epithelial Na+ channel (rENaC), the rate-limiting step in
epithelial Na+ transport, consists of three subunits,
,
, and
. We hypothesized that
-rENaC translation is regulated
via its 5'-untranslated region (UTR). Transient transfections of
-rENaC promoter-reporter constructs in representative epithelial
cell lines demonstrated up to fivefold differences in activity among
constructs containing different amounts of the
-rENaC 5'-UTR
sequence. Differences in reporter protein activity did not parallel
differences in reporter mRNA, demonstrating that 5'-UTR regulation must
be at the level of translation. Specifically, translation was enhanced
by a region extending from +53 to +211 bp downstream from the
transcription start site and repressed by the region between +367 and
+499 bp. Examination of the 5'-UTR sequence revealed an out-of-frame
initiation codon within the repressive region, 43 bp upstream from the
start of the
-rENaC open reading frame. Mutational analysis of this upstream start codon indicated that it plays, at most, a minor role in
impeding translation both in vitro and in vivo, suggesting that
additional mechanisms of translational regulation are operative.
rat epithelial sodium channel; 5'-untranslated region; lung fluid; ion transport; translational regulation
| |
INTRODUCTION |
|---|
|
|
|---|
THE AMILORIDE-SENSITIVE
EPITHELIAL Na+ channel (ENaC) (reviewed in
Refs. 12, 26, 53) is expressed in the apical membrane of
salt-absorbing epithelia found in the kidney, colon, and lung where it
constitutes the rate-limiting step in active Na+ and fluid
absorption. It thus plays a major role in the regulation of salt
homeostasis and blood pressure as indicated by the existence of genetic
hypertensive and hypotensive diseases associated with ENaC gene
mutations, such as Liddle's syndrome (45) and
pseudohypoaldosteronism type 1 (5). In the lung, ENaC is
important in controlling the amount of liquid in the lung airspace.
Targeted "knockout" of the gene for the
-subunit of ENaC in mice
gave rise to newborns that suffered respiratory distress, were unable
to clear their fetal lung liquid, and died within 2 days of birth
despite having morphologically normal lungs (17).
ENaC, which consists of three homologous subunits,
,
and
, is
part of a novel cation channel superfamily (12). ENaC subunits have been cloned from many species including human and rat. In
heterologous expression systems (Xenopus oocytes),
amiloride-sensitive Na+ currents can be measured in oocytes
injected with rat
-ENaC (
-rENaC) mRNA; coexpression of all three
subunits is required for maximal activity (3). In the
oocyte expression system, both a heterotetrameric structure containing
two
-, one
-, and one
-subunit (11, 23) and a
nonameric structure containing three copies of each subunit (9,
47) have been proposed. Regardless of which model represents the
correct protein subunit stoichiometry, no more than a twofold excess of
the
- over
- and
-subunits is predicted. However, our
laboratory has found that
-ENaC mRNA is expressed at
markedly greater levels than
- and
-subunit mRNAs in respiratory
tract epithelia; we observed mRNA ratios of 20:4:1 in human
(31) and 50:1:5 in mouse (19) nasal turbinate
by quantitative competitive reverse transcription-polymerase chain
reaction (RT-PCR). This agrees with relative estimates by Northern
analysis and in situ hybridization (2, 10, 27, 50) and
suggests that
-ENaC mRNA, under normal conditions, may be less
efficiently translated than
- and
-subunit mRNAs.
-ENaC has
been shown to be capable of expressing functional channels in the
absence of the
- and
-subunits when this subunit is artificially expressed alone (4, 21); however, the heteromultimer
appears to be the preferred form of assembly, unaltered even by
injection of a 100-fold excess quantity of message encoding a single
subunit (11). Thus it is unlikely that formation of
homomultimeric channels accounts for the excess
-ENaC mRNA expression.
Several observations suggest a possible role for the 5'-untranslated
region (UTR) in the translational regulation of
-ENaC. First, Smith
et al. (46) have recently demonstrated that
-ENaC mRNA
expression is detectable during the earliest stages of fetal lung
development, at a time when the lung is a secretory and not an
absorptive organ. Second, it has been shown that multiple
-ENaC mRNAs differing in the 5'-UTR are expressed in human tissue
(51). Both human and rat
-ENaC 5'-UTRs are unusually
long [up to 750 nucleotides (nt); most 5'-UTRs are 50-100 nt]
and contain GC-rich regions, indicating a potential secondary structure
(30). Finally, a study by Otulakowski et al.
(30) revealed a decrease in reporter gene activity in
transfected A549 cells when
-rENaC promoter constructs were extended
to include an additional 133 bp of the 5'-UTR. These observations
suggest the presence of a negative regulatory element. Due to its
location, such an element could be functionally active during either
transcription or translation. Structural features in mRNA 5'-UTRs that
may influence translational efficiency are secondary structure,
occurrence of upstream AUG start codons, structural motifs recognized
by specific binding proteins, and internal ribosome entry sites
(6, 16, 24, 25, 32, 37, 49).
To study the translational regulation of
-rENaC, we developed a
quantitative competitive RT-PCR assay to assess reporter mRNA levels in
transiently transfected cells and examined the effect of different
regions of 5'-UTR on reporter gene mRNA and protein expression.
Mutational analysis was used to investigate the potential influence of
an upstream, out-of-frame initiation codon in the
-rENaC 5'-UTR.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Promoter-reporter constructs.
Cloned genomic DNA fragments containing portions of the putative
-rENaC promoter were inserted upstream of the secreted alkaline phosphatase (SEAP) gene in the promoterless expression vector pSEAP2-basic (Clontech, Palo Alto, CA). A combination of naturally occurring restriction sites and fragments generated by exonuclease digestion was used to assemble the reporter constructs. The sequence ATG at +473-475 bp was mutated to TTG by sequential PCR steps. The
resulting PCR fragment was cloned into pBluescript II KS(
); the
sequence was confirmed and then substituted for the wild-type sequence
in the "dSEAP2" construct series to generate the "dmOSEAP2" constructs.
Cell culture.
Madin-Darby canine kidney (MDCK) epithelial cells were maintained in
Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine
serum (FBS). Mouse kidney cortical collecting duct epithelial cells
(M1) were maintained in DMEM plus Ham's F-12 medium (1:1) with 5% FBS
and 5 µM dexamethasone. Human lung epithelial cells (NCI-H441) were
maintained in RPMI 1640 medium with 10% FBS. Mouse distal lung
epithelial cells (MLE-15) were maintained in HITES medium with 2% FBS.
HITES medium consisted of RPMI 1640 medium supplemented with 5 µg/ml
of insulin, 10 µg/ml of transferrin, 30 nM sodium selenite, 10 nM
hydrocortisone, 10 nM
-estradiol, 10 mM HEPES, and 2 mM
L-glutamine. MLE-15 cells were a gift from Dr. J. Whitsett
(Children's Hospital Medical Center, Cincinnati, OH); all other cell
lines were obtained from the American Type Culture Collection
(Manassas, VA). All lines were maintained in the presence of 100 U/ml
of penicillin G and 100 µg/ml of streptomycin sulfate.
DNA sequencing. Manual sequencing was carried out with the Pharmacia T7 sequencing kit (Amersham Pharmacia Biotech, Baie d'Urfé, PQ) and 35S-dATP. Automated sequencing reactions were performed with a Thermo Sequenase fluorescent-labeled primer cycle sequencing kit with 7-deaza-dGTP (Amersham) and analyzed on a LICOR DNA sequencer model 4000L equipped with Base ImagIR software (LI-COR, Lincoln, NE).
Transfections.
Cells were plated in six-well tissue culture dishes at 2.5 × 105 cells/well for MDCK cells, 4 × 105
cells/well for M1 cells, and 8 × 105 cells/well for
MLE-15 and H441 cells 18 h before transfection. Cells were
cotransfected with pSEAP2 constructs and a Rous sarcoma virus
(RSV)-driven
-galactosidase (
gal)-expressing plasmid (RSV
gal) as an internal control for transfection efficiency. Transfections were
carried out with LipofectAMINE reagent or LipofectAMINE Plus for H441
cells (Life Technologies) according to the manufacturer's recommendations. Medium was collected 48 h posttransfection for analysis of SEAP activity with a Phospha-Light chemiluminescence kit
(PerkinElmer Applied Biosystems Division, Mississauga, ON).
-Galactosidase activity was determined via a colorimetric assay with
o-nitrophenyl-
-D-galactopyranoside as
described previously (13) on cell extracts prepared by
lysis of cultured cells in 1% Triton X-100-0.25 M
Tris · HCl, pH 7.8.
Quantitative RT-PCR.
A competitive internal control, RSV
SEAP, for quantitative RT
(QRT)-PCR in transiently transfected cells was created by deleting a
218-bp NarI fragment from the SEAP coding region of an RSV
promoter-driven pSEAP construct. ENaC promoter-driven SEAP2 constructs
were cotransfected with RSV
SEAP at a ratio of 100:1 as described in
Transfections. All transfections were carried out in
triplicate. Forty-eight hours posttransfection, the cells were
harvested by direct addition of lysis buffer (RLT buffer, QIAGEN, Santa
Clarita, CA), and total RNA was purified with the RNeasy Mini Kit
(QIAGEN). The resulting RNA was treated with RNase-free DNase and again
purified on an RNeasy column. RNA was quantitated by ultraviolet spectrophotometry.
SEAP such that ENaC promoter-driven SEAP
constructs give rise to a 663-bp product and RSV
SEAP gives rise to a
446-bp product. Two-step QRT-PCR was carried out with 1 µg of RNA
from transfected cells. Each RT reaction contained 1× first-strand
synthesis buffer (Life Technologies), 10 mM dithiothreitol, 0.5 mM
deoxynucleotide triphosphates, 1 U/µl of RNAguard (Pharmacia Biotech), 0.25 µM primer SEAP2, and 50 U of SuperScript II reverse transcriptase (Life Technologies) in a final volume of 20 µl. RT was
carried out for 45 min at 50°C. PCRs contained 1× Thermopol reaction
buffer (New England Biolabs, Mississauga, ON), 0.1 mM deoxynucleotide
triphosphates, 0.1 µM primers SEAP1 and SEAP2, 5 µl of RT reaction
products, 5% (vol/vol) DMSO, and 0.5 U of Vent(exo-) polymerase (New
England Biolabs). Amplification was carried out for 31 cycles
consisting of 30 s at 94°C, 30 s at 55°C, and 1 min at
72°C in a PerkinElmer 9600 thermocycler. PCR products were analyzed
by electrophoresis on an 8% nondenaturing polyacrylamide gel followed
by ethidium bromide (5 µg/ml) staining. Intensity of the fluorescent
bands was quantitated with the NIH Image program (developed at the
National Institutes of Health and available on the Internet at
http://rsb.info.nih.gov/nih-image/).
In vitro transcription and translation.
Templates for in vitro transcription were constructed in pBluescript II
KS(
). Template
L contains the
-rENaC cDNA sequence from +53 nt
through the poly(A)+ tail;
S contains the
-rENaC
full-length cDNA sequences from +420 nt through the
poly(A)+ tail [
-rENaC open reading frame (ORF)
initiates at +517 nt].
SM and
LM contain the corresponding
sequences, with mutation of the upstream ATG at +473-475 nt to TTG
as described for the promoter-reporter constructs. Templates were
linearized 3' to the poly(A)+ tail with XhoI.
Capped mRNAs were generated with T7 RNA polymerase with mMESSAGE
mMACHINE (Ambion) and quantitated by ultraviolet spectrophotometry.
Aliquots were examined by electrophoresis on formaldehyde-containing
agarose gels to verify length and confirm that mRNA was not degraded.
We used 0.8 pmol of each capped mRNA to prime in vitro translation
reactions containing [35S]methionine (
1,000 Ci/mmol;
ICN, Cosa Mesa, CA) with a ReticLysate IVT kit (Ambion). The resulting
proteins were analyzed on Laemmli SDS-polyacrylamide gels, subjected to
fluorography with Amplify (Amersham Pharmacia Biotech), and exposed to
Kodak X-OMAT film. For quantitation of synthesized protein, the dried
gels were imaged with a Molecular Dynamics STORM 840 phosphorimager
equipped with ImageQuant Software (Amersham Pharmacia Biotech).
Statistical analysis. All data are presented as means ± SE, and significances were calculated with one-way ANOVA. P < 0.05 was considered to be significant. Statistical analysis was carried out with GraphPad InStat version 3.01 (GraphPad Software, San Diego CA).
| |
RESULTS |
|---|
|
|
|---|
-rENaC promoter activity in lung and kidney epithelial cell
lines.
In the present study, we created a series of promoter-reporter
constructs (Fig. 1) extending up to 4,539 bp upstream and 499 bp downstream of the
-rENaC +1 transcription
start site. We characterized the basal and steroid hormone-stimulated
activity of these constructs in representative kidney (MDCK and M1) and
lung (MLE-15 and H441) epithelial cell lines (Fig.
2).
|
|
-rENaC constructs in the
MDCK, M1, MLE-15, and H441 cell lines was at least twice as high as
they had obtained in COS-7 and A549 cells. Activity of the
glucocorticoid-responsive element previously described (30), located between
552 and
1,054 nt, is evident in
M1 and MLE-15 cells, which are cultured in medium containing steroid hormone (Fig. 2, B and C; note the log scale);
relative activity of 1051SEAP2 in the presence of glucocorticoid
stimulation reached 61-fold in M1 cells and 47-fold in MLE-15, in
contrast to the modest 5-fold activity previously reported by
Otulakowski et al. (30) in COS-7 cells . When
dexamethasone (M1 cells) or hydrocortisone (MLE-15 cells) is eliminated
from the medium during the posttransfection period, 1051-series
constructs yield activities comparable to the 548-series constructs
(data not shown).
Otulakowski et al. (30) previously reported the presence
of a negative regulatory element in the +367- to +499-nt region, significant in the lung carcinoma line A549 but not in the
fibroblast-like kidney line COS-7. In all four of the kidney and lung
epithelial cell lines tested in these studies, this element was active,
reducing activity by up to 70% (P < 0.01; Fig. 2,
SEAP2 vs. dSEAP2). This repressive effect is maintained even in the
presence of steroid induction; reporter activity of 1051-, 1474-, and
5000dSEAP2 constructs in M1 and MLE-15 cells (Fig. 2, B and
C) was ~50% lower than the corresponding 1051-, 1474-, and 5000SEAP2 constructs.
We examined the role of sequences within the 5'-UTR further by
generating additional constructs. The PvuSEAP2 constructs (Fig. 2),
which shortened the 5'-UTR to 211 bp, resulted in an increase in
activity in three cell lines as would be expected on decreasing the
length of the 5'-UTR; however, this effect did not always reach
significance. Further truncation, to +53 nt ("-uSEAP2" constructs; Fig. 2), resulted in a decrease in activity in M1, MLE-15, and H441
cells to levels similar to constructs extending to +367 nt. This
difference between uSEAP2 and PvuSEAP2 constructs was significant regardless of the length of the upstream promoter. Taken together, these experiments suggest a positive element located in the 53- to
211-bp region, operational in H441, MLE-15, and M1 cell lines. The
enhancement of reporter gene expression ranged from 33 to 86%
depending on the cell line and promoter context. Although this is a
modest effect, we feel it is significant because increasing the 5'-UTR
length from 53 to 211 bp would normally decrease, rather than increase,
protein expression.
Reporter mRNA levels in transiently transfected cells.
Because the regulatory regions identified between +53 and +499 nt are
located downstream from the transcriptional start site, it is
impossible to tell from SEAP enzyme activity alone whether they are
modifying transcription initiation, mRNA stability, or mRNA
translational efficiency. To begin to clarify the process through
which these elements act, we designed a control plasmid to allow
quantitative RT-PCR analysis of reporter gene mRNA levels in
transfected cells. RSV
SEAP contains a small deletion in the region
encoding the COOH terminus of SEAP protein; primers flanking this
sequence were designed such that RT-PCR amplification products of
full-length SEAP and
SEAP mRNAs can be distinguished on the basis of
size. RSV
SEAP was cotransfected with 548uSEAP2, 548PvuSEAP2, 548SEAP2, and 548dSEAP2 such that it would serve both as a control for
transfection efficiency and as an internal, competitive control for
QRT-PCR.
-rENaC promoter-driven SEAP reporters (Fig. 3B)
despite significant differences in SEAP enzyme activity (Fig.
3C). In the lung epithelial cell line MLE-15, the sequence
between +211 and +367 nt did significantly decrease reporter gene mRNA
expression in transiently transfected cells (Fig.
4B); however, the associated
decrease in reporter gene activity was not significant (Fig.
4C). Both cell types consistently showed that extension of
the promoter constructs from +53 to +211 nt (Fig. 4) induced a
significant doubling of reporter gene enzyme activity in the absence of
any significant change in mRNA levels. In addition, SEAP enzyme
activity was significantly decreased by extension of the constructs
from +367 to +499 nt (Fig. 4), again in the absence of any change in
reporter gene mRNA levels. These data indicate that differences in SEAP
enzyme activity result from differences in the efficiency of
translation of the SEAP mRNAs expressed from the different reporter
constructs rather than from differences in transcription rate or mRNA
stability. Specifically, they suggest the existence of a sequence
element enhancing translation located between +53 and +211 nt and an
element repressing translation between +367 and +499 nt.
|
|
Effect of the +367- to +499-nt
region in the context of uSEAP2 reporters.
The decrease in reporter gene expression seen when extending the
-rENaC 5'-UTR from +367 to +499 nt may simply be due to increasing
the length of the 5'-UTR past a certain threshold. To investigate this,
we deleted bases from +54 to +366 nt, effectively moving the +367- to
+499-nt region directly adjacent to the 3'-end of the uSEAP2 constructs
(Fig. 1,
dSEAP2 constructs). As shown in Fig.
5, the
dSEAP2 constructs exhibited
decreased reporter gene activity compared with their corresponding
uSEAP2 reporters, although this inhibition was approximately half as
great as that seen with the full-length dSEAP2 constructs. The decrease
failed to reach significance in the 1051-series constructs in the
kidney cell lines MDCK and M1 and in the 5000-series constructs in the lung cell lines MLE-15 and H441. The effect did not appear to be
modified under conditions of steroid induction of the reporter gene in
M1 or MLE-15 cells (Fig. 5, B and C).
|
Effect of upstream ORF on mRNA translation.
The sequence of the
-rENaC 5'-UTR is indicated in Fig.
6. Adjacent AUG codons initiating the
-rENaC ORF are underlined at +517 nt. Note the existence of an AUG
codon upstream and out-of-frame initiation codon with the
-rENaC
protein-coding region, initiating an upstream ORF (uORF) at +473 nt.
Such upstream initiation codons have frequently been reported to exert
negative effects on translation initiation at the correct, downstream
initiation codon (14). None of the AUG codons exist in an
optimal Kozak consensus sequence (RCCAUGG, with R at
3 nt and G at +4
nt being most influential) (25). Thus we hypothesized that
the initiation of protein synthesis at the upstream AUG was inhibiting
translation of the SEAP reporter (with which it is also out of frame in
our constructs) in "-dSEAP2" constructs. We therefore mutated the
upstream ATG sequence in our SEAP reporter constructs to TTG, thus
eliminating the initiation codon of the uORF. The results of this
mutation are shown in Fig. 7
(dmOSEAP2 constructs). Surprisingly, removal of the uORF had little effect, restoring activity convincingly only in
kidney-derived cell lines (Fig. 7, A and B)
transfected with constructs containing minimal amounts of the upstream
promoter (297dmOSEAP2 and 548dmOSEAP2). In lung-derived epithelial cell
lines (Fig. 7, C and D), no significant increase
in reporter gene activity resulted from the uORF mutation except in
MLE-15 cells transfected with 297dmOSEAP2, where a partial restoration
of activity was seen.
|
|
Effects of
-rENaC 5'-UTR on translational efficiency in vitro.
To confirm the effects of the
-rENaC 5'-UTR on translation
efficiency in conjunction with the
-rENaC protein-coding region, as
opposed to heterologous reporter constructs, we created four templates
suitable for in vitro transcription and translation of
-rENaC
protein (Fig.
8A).
Equimolar amounts of capped
-rENaC transcripts containing either 97 (
S and
SM) or 464 (
L and
LM) nt of the
-rENaC 5'-UTR
were used to direct protein synthesis in a reticulocyte lysate system.
Radiolabeled protein products were analyzed by SDS-PAGE as demonstrated
in Fig. 8B. All four templates gave rise to a specific
protein product at 72 kDa, consistent with the expected size of in
vitro translated
-rENaC. Considerably more protein was produced from
RNA transcripts containing the truncated 5'-UTR (compare protein
produced from
S with
L). To confirm these observations,
-rENaC
protein was quantitated from three independent transcription or
translation experiments (Fig. 8C). As in transient
transfections, mutation of the upstream AUG resulted in only a small
increase in translational efficiency, which was significant only in the
context of the truncated UTR.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have presented evidence that suggests that the 5'-UTR of
-rENaC mRNA plays a role in regulating ENaC expression. The overall inhibitory effect of the long
-rENaC 5'-UTR is clear in our in vitro
translation experiments. Transient transfection experiments indicated
the existence of specific positive and negative translational regulatory elements within the 5'-UTR. Specifically, the region located
between +53 and +211 nt increased the expression of a linked reporter
gene in a variety of cell lines without increasing the amount of mRNA
expressed. A second region of interest, located between +367 and +499
nt, severely inhibited translation of a linked reporter gene. In
general, one would expect expression to decrease with increasing length
of the 5'-UTR. The inhibitory effect of the +367- to +499-nt region was
tested in the context of a shorter
-rENaC 5'-UTR, i.e., in the
dSEAP2 constructs (Fig. 5). Interpretation of the data from the
dSEAP2 constructs is complicated because they delete the putative
positive regulatory region from +54 to +211 nt. However, it is clear
from Fig. 2A that the +54- to +211-nt region has no effect
in MDCK cells. In Fig. 2A, expression was not affected by
increasing the amount of
-rENaC 5'-UTR from 53 nt (uSEAP2) to 211 nt
(PvuSEAP2) or even further to 367 nt (SEAP2) in MDCK cells. Yet the
dSEAP2 constructs, with only 186 nt of
-rENaC 5'-UTR, generated
significantly less reporter gene expression than the uSEAP2 constructs
(Fig. 5A). Similar results were seen in other cell lines
(Fig. 5, B-D). The inhibition was only about
half as much as was seen with the intact 499-nt UTR region (dSEAP2
constructs), suggesting that either total length or possibly secondary
structure interactions between the +367- to +499-nt region and the
deleted sequences also play a role. Overall, the data suggest that the
decrease in translation efficiency seen when extending the 5'-UTR from +367 to +499 nt is not solely due to increasing the length of the
5'-UTR.
In a previous publication, Otulakowski et al. (30) reported the existence of an additional transcription start site in this region, at position +455, detectable by conventional 5'-rapid amplification of cDNA ends and primer extension. As seen in Figs. 3 and 4, this region does not increase transcription (SEAP mRNA levels) in transiently transfected M1 or MLE15 cells, and we have subsequently been unable to demonstrate transcripts initiating at this site with a RNase protection assay (Otulakowski and O'Brodovich, unpublished data). A GC-rich sequence immediately upstream of +455 nt may have impeded RT through this region in 5'-rapid amplification of cDNA ends and primer extension.
The upstream, out-of-frame initiation codon in this region seems to mediate only a minor component of the translational repression as demonstrated by the effects of point mutation of the upstream start codon in both transfected cells and in vitro translation systems. Our data thus suggest that an additional level of translational repression is conferred by this region, which may be specific to lung, because point mutation of the upstream AUG restored reporter gene activity to a lesser extent in MLE-15 or H441 cells than in MDCK and M1 cells. We do not presently understand the mechanism by which mutation of the upstream AUG restored activity only in constructs containing a "minimal" promoter, but the observation suggests that translational inhibition mediated by the 5'-UTR may be influenced by sequences in the 5'-flanking region and may be subject to cell- or tissue-specific effects. As discussed above, Fig. 5 suggests the influence of the region between +367 and +499 nt may also be dependent on promoter context and cell line in transient transfections.
The importance of control of eukaryotic gene expression at the level of translation is now well recognized (see Refs. 14, 40, 41 for recent reviews). Specific sequences within mRNA UTRs can modulate translational efficiency in a tissue- and developmental stage-specific manner. Most translational effects are exerted at the level of protein chain initiation with a combination of specific sequence features in the 5'- or 3'-UTRs of mRNAs and/or physiological regulation of initiation factor activities.
Experimental studies with both in vivo and in vitro systems clearly
demonstrate that mRNAs with a high potential to form a stable secondary
structure in the 5'-UTR tend to be translated inefficiently (7,
24, 25, 36). Tissue-specific use of alternative promoters to
produce transcripts with different 5'-UTRs having varying amounts of
secondary structure has been reported, for example, for the human
-folate receptor (49) and insulin-like growth factor II
(29). Mechanisms permitting the regulated release of this
translational repression in response to specific signals are not
completely understood. One possibility is the activation of general
initiation factors involved in mRNA binding (e.g., by phosphorylation)
(1). Alternative use of a shorter, more efficiently
translated leader sequence may also occur in response to some
developmental (6, 35) or environmental (6,
54) cue. In this context, it is interesting to note that human
-ENaC mRNAs differing in the 5'-UTR through use of alternative
transcriptional start sites have been reported (30, 51).
The presence of upstream AUG codons in the 5'-UTR can also affect the efficiency of translation initiation of the main ORF. In >90% of mRNAs, the AUG initiating the main ORF is the first AUG encountered when scanning from the 5'-end (25). Additional upstream AUGs tend to severely decrease the efficiency of initiation at the correct AUG, but these effects can be tissue specific (18, 20, 39).
Structural motifs in mRNA molecules can provide sites for the binding of specific proteins. In the case of the 5'-UTR, such binding can impede initiation by stabilizing an element of the secondary structure not itself strong enough to be inhibitory (15, 16). Most recently, the identification of internal ribosome entry sequence (IRES) elements in the 5'-UTR in a variety of capped eukaryotic mRNAs has led to the discovery of an alternative mechanism of translation initiation that can function as an alternative to "scanning" the 5'-UTR by the 43S preinitiation complex. Usage of IRES-mediated translational initiation can avoid the inhibitory effects of the secondary structure at the 5'-end of the mRNA and may be physiologically regulated (32).
The observation that the mRNA encoding
-ENaC in both humans
and rats contains an unusually long 5'-UTR burdened with GC-rich regions indicates immediately that this mRNA is probably inefficiently translated and may explain the relative abundance of
-ENaC mRNA compared with
- and
-ENaC mRNAs in native tissue. Furthermore, the observation of tissue (51) and developmental
(30) regulation of the expression of alternative 5'-UTRs
suggests that translational regulation may play a role in controlling
ENaC synthesis. Our data now indicate that the
-rENaC 5'-UTR
contains sequence elements exerting both positive and negative effects
on translation of the downstream ORF. The mechanism by which these
elements function is not yet elucidated, and a number of possibilities
exist based on the examples given above. The positive element 53- to
211-bp region may contain sequences that bind regulatory proteins,
influence secondary structure, or contain an IRES, allowing recruitment of ribosomes downstream of secondary structure at the extreme 5'-end of
the mRNA. The negative effects of the 367- to 499-bp sequence appear to
be only minimally mediated via the upstream AUG, suggesting that
secondary structure or specific regulatory proteins may be involved in
this region also. The translational efficiency of mRNAs burdened with a
secondary structure in the 5'-UTR is susceptible to regulation via cell
signaling cascades that modify assembly of the eukaryotic translation
initiation complex eIF4F, which is responsible for unwinding the
secondary structure.
The number of functional ENaCs on the cell surface is small and tightly
regulated. Previous studies (34, 48, 52) have shown that
most of the channel proteins remain in a core-glycosylated form in
pre-Golgi compartments and are subsequently degraded before ever
reaching the plasma membrane. This has led to the suggestion that the
limiting steps for the accumulation of functional channels in the
plasma membrane are the processes of assembly and maturation of the
subunits in the endoplasmic reticulum (52). However, these
studies have been carried out in heterologous expression systems
(Xenopus oocytes and transfected mammalian cells) and used
-ENaC cDNAs that lack the extended 5'-UTRs concurrently reported in
both rats (30) and humans (51). Consequently, it is possible that much less
-ENaC protein would be produced from
the endogenous mRNAs than was seen in the heterologous systems, possibly eliminating the buildup of excess unassembled protein in the
endoplasmic reticulum. Little information is available on the
biosynthesis and trafficking of endogenous ENaC; however, May et al.
(28) have examined the rate of synthesis of
-,
-, and
-ENaC subunit proteins in A6 cells. After aldosterone treatment, an increase in the rate of synthesis of
-ENaC protein preceded the
increase in
-ENaC mRNA. This led the authors to suggest that synthesis of the
-subunit was a limiting factor in channel assembly and that aldosterone may selectively increase translation of existing
-ENaC mRNAs.
More recently, the serum- and glucocorticoid-dependent kinase
sgk has been identified as an early, aldosterone-induced
gene that is a likely candidate to mediate the early increase in ENaC activity in response to aldosterone. Although aldosterone induces phosphorylation of the carboxy termini of
- and
-ENaC subunits when the channel is expressed in MDCK cells (44),
sgk appears not to phosphorylate ENaC directly
(8) nor to affect its degradation (43).
Although many scenarios by which a kinase signaling cascade can lead to
an increase in ENaC cell surface expression are possible, one
hypothesis consistent with our observations and those of May et al.
(28) would be a kinase-mediated increase in the
translation initiation of ENaC mRNAs. Specifically, the eukaryotic
translation initiation factor eIF4E, which has been suggested to be
limiting for translation in vivo, is serine phosphorylated in response to growth factors, hormones, and mitogens (reviewed in Ref. 14). Phosphorylation of eIF4E enhances its activity, resulting in increased delivery of eIF4F (an RNA helicase) to the 5'-UTR, disrupting the
secondary structure. In fact, in mammalian cells, overexpression of
eIF4E results in a more efficient translation of reporter mRNAs containing structured 5'-UTRs (22) and has been shown to
enhance translation of a number of mRNAs such as cyclin D1
(38) and ornithine decarboxylase with structure-rich
5'-UTRs (42). Thus it is plausible that aldosterone
induces a rapid increase in ENaC protein synthesis by specifically
increasing the efficiency of translation initiation of
-ENaC.
Understanding of mRNA cellular biology, such as regulation of splicing,
subcellular trafficking, translation efficiency, and stability, has
generally lagged behind our knowledge of functional mechanisms
involving DNA and proteins. However, the important role that UTRs of
eukaryotic mRNAs play in gene expression is becoming more widely
recognized and has led to the recent creation of a specialized database
of 5'- and 3'-UTR sequences and functional elements (33).
-ENaC mRNAs from both rats and humans are clearly burdened with
unusually long 5'-UTRs. Our study using recombinant DNA constructs
indicates that the 5'-UTR contains regions capable of regulating ENaC
expression at the translational level. An investigation of the
translational efficiency of endogenous
-rENaC mRNA via polysome
gradient analysis will be required to prove the physiological significance of these effects. Regulation at the translational level,
probably in combination with ENaC assembly and trafficking, would
enable ENaC-expressing tissues to respond more quickly to environmental
signals than de novo transcription would permit.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by a Canadian Institutes of Health Research Group Grant in Lung Development.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: G. Otulakowski, Programme in Lung Biology Research, Hospital for Sick Children Research Institute, 555 University Ave., Toronto, Ontario M5G 1X8, Canada (E-mail: gotulak{at}sickkids.on.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 8 September 2000; accepted in final form 26 July 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Brown, EJ,
and
Schreiber SL.
A signaling pathway to translational control.
Cell
86:
517-520,
1996[Web of Science][Medline].
2.
Burch, LH,
Talbot CR,
Knowles MR,
Canessa CM,
Rossier BC,
and
Boucher RC.
Relative expression of the human epithelial Na+ channel subunits in normal and cystic fibrosis airways.
Am J Physiol Cell Physiol
269:
C511-C518,
1995
3.
Canessa, CM,
Horisberger JD,
and
Rossier BC.
Functional cloning of the epithelial sodium channel: relation with genes involved in neurodegeneration.
Nature
361:
467-470,
1993[Medline].
4.
Canessa, CM,
Schild L,
Buell G,
Thorens B,
Gautschi I,
Horisberger JD,
and
Rossier BC.
Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.
Nature
367:
463-467,
1994[Medline].
5.
Chang, SS,
Grunder S,
Hanukoglu A,
Rosler A,
Mathew PM,
Hanukoglu I,
Schild L,
Lu Y,
Shimkets RA,
Nelson-Williams C,
Rossier BC,
and
Lifton RP.
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.
Nat Genet
12:
248-253,
1996[Web of Science][Medline].
6.
Cianetti, L,
Di Cristofaro A,
Zappavigna V,
Bottero L,
Boccoli G,
Testa U,
Russo G,
Boncinelli E,
and
Peschle C.
Molecular mechanisms underlying the expression of the human HOX-5.1 gene.
Nucleic Acids Res
18:
4361-4368,
1990
7.
Curnow, KM,
Pascoe L,
Davies E,
White PC,
Corvol P,
and
Clauser E.
Alternatively spliced human type 1 angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms.
Mol Endocrinol
9:
1250-1262,
1995
8.
De la Rosa, DA,
Zhang P,
Naray-Fejes-Toth A,
Fejes-Tóth G,
and
Canessa C.
The serum and glucocorticoid kinase sgk increases the abundance of epithelial sodium channels in the plasma membrane of Xenopus oocytes.
J Biol Chem
274:
37834-37839,
1999
9.
Eskandar, S,
Snyder PM,
Kreman M,
Zampighi GA,
Welsh MJ,
and
Wright EM.
Number of subunits comprising the epithelial sodium channel.
J Biol Chem
274:
27281-27286,
1999
10.
Farman, N,
Talbot CR,
Boucher R,
Fay M,
Canessa C,
Rossier B,
and
Bonvalet JP.
Noncoordinated expression of
-,
-, and
-subunit mRNAs of epithelial Na+ channel along rat respiratory tract.
Am J Physiol Cell Physiol
272:
C131-C141,
1997
11.
Firsov, D,
Gautschi I,
Merillat AM,
Rossier BC,
and
Schild L.
The heterotetrameric architecture of the epithelial sodium channel (ENaC).
EMBO J
17:
344-352,
1998[Web of Science][Medline].
12.
Garty, H,
and
Palmer LG.
Epithelial sodium channels: function, structure, and regulation.
Physiol Rev
77:
359-396,
1997
13.
Giguère, V,
Shago M,
Zirngibl R,
Tate P,
Rossant J,
and
Varmuza S.
Identification of a novel isoform of the retinoic acid receptor gamma expressed in the mouse embryo.
Mol Cell Biol
10:
2335-2340,
1990
14.
Gray, NK,
and
Wickens M.
Control of translation initiation in animals.
Annu Rev Cell Dev Biol
14:
399-458,
1998[Web of Science][Medline].
15.
Gu, W,
and
Hecht NR.
Translation of a testis-specific Cu/Zn superoxide dismutase (SOD-1) mRNA is regulated by a 65-kilodalton protein which binds to its 5' untranslated region.
Mol Cell Biol
16:
4535-4543,
1996[Abstract].
16.
Hentze, MW,
and
Kuhn LC.
Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress.
Proc Natl Acad Sci USA
93:
8175-8182,
1996
17.
Hummler, E,
Barker P,
Gatzy J,
Beermann F,
Verdumo C,
Schmidt A,
Boucher R,
and
Rossier BC.
Early death due to defective neonatal lung liquid clearance in
ENaC-deficient mice.
Nat Genet
12:
325-328,
1996[Web of Science][Medline].
18.
Iwaki, A,
Iwaki T,
Goldman JE,
and
Liem R.
Multiple mRNAs of rat brain
-crystallin B chain result from alternative transcriptional initiation.
J Biol Chem
265:
22197-22203,
1990
19.
Kassovska-Bratinova, S,
Vannam V,
Freywald T,
Otulakowski G,
and
O'Brodovich H.
Absence of detectable amiloride-sensitive ion transport in murine tracheal epithelia may result from lack of
-ENaC mRNA expression (Abstract).
Am J Respir Crit Care Med
161:
A234,
2000.
20.
Kilpatrick, DL,
Zinn SA,
Fitzgerald M,
Higuchi H,
Sabol SL,
and
Meyerhardt J.
Transcription of the rat and mouse proenkephalin genes is initiated at distinct sites in spermatogenic and somatic cells.
Mol Cell Biol
10:
3717-3726,
1990
21.
Kizer, N,
Guo XL,
and
Hruska K.
Reconstitution of stretch-activated cation channels by expression of the
-subunit of the epithelial sodium channel cloned from osteoblasts.
Proc Natl Acad Sci USA
94:
1013-1018,
1997
22.
Koromilas, AE,
Lazaris-Karatzas A,
and
Sonenberg N.
mRNAs containing extensive secondary structure in their 5' non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E.
EMBO J
11:
4153-4158,
1992[Web of Science][Medline].
23.
Kosari, F,
Sheng S,
Li J,
Mak DOD,
Foskett JK,
and
Kleyman TR.
Subunit stoichiometry of the epithelial sodium channel.
J Biol Chem
273:
13469-13474,
1998
24.
Kozak, M.
An analysis of vertebrate mRNA sequences: intimations of translational control.
J Cell Biol
115:
887-903,
1991
25.
Kozak, M.
Structural features in eukaryotic mRNAs that modulate the initiation of translation.
J Biol Chem
266:
19867-19870,
1991
26.
Matalon, S,
and
O'Brodovich H.
Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance.
Annu Rev Physiol
61:
627-661,
1999[Web of Science][Medline].
27.
Matsushita, K,
McCray PB, Jr,
Sigmund RD,
Welsh MJ,
and
Stokes JB.
Localization of epithelial sodium channel subunit mRNAs in adult rat lung by in situ hybridization.
Am J Physiol Lung Cell Mol Physiol
271:
L332-L339,
1996
28.
May, A,
Puoti A,
Gaeggeler HP,
Horisberger JD,
and
Rossier BC.
Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel
subunit in A6 renal cells.
J Am Soc Nephrol
8:
1813-1822,
1997[Abstract].
29.
Nielsen, FC,
Gammeltoft S,
and
Christiansen J.
Translational discrimination of mRNAs coding for human insulin-like growth factor II.
J Biol Chem
265:
13431-13434,
1990
30.
Otulakowski, G,
Rafii B,
Bremner HR,
and
O'Brodovich H.
Structure and hormone responsiveness of the gene encoding the
-subunit of the rat amiloride-sensitive epithelial sodium channel.
Am J Respir Cell Mol Biol
20:
1028-1040,
1999
31.
Otulakowski, G,
Staub SF,
Ellis L,
Ramlall K,
Staub O,
Smith D,
Durie P,
and
O'Brodovich H.
Relation between
,
,
hENaC mRNA levels and nasal epithelial potential difference in healthy men.
Am J Respir Crit Care Med
157:
1213-1220,
1998
32.
Pain, VM.
Initiation of protein synthesis in eukaryotic cells.
Eur J Biochem
236:
747-771,
1996[Web of Science][Medline].
33.
Pesole, G,
Liuni S,
Grillo G,
Licciulli F,
Larizza A,
Makalowski W,
and
Saccone C.
UTRdb and UTRsite: specialized databases of sequences and functional elements of 5' and 3' untranslated regions of eukaryotic mRNAs.
Nucleic Acids Res
28:
193-196,
2000
34.
Prince, LS,
and
Welsh MJ.
Cell surface expression and biosynthesis of epithelial Na+ channels.
Biochem J
336:
705-710,
1998.
35.
Reynolds, PJ,
Lesley J,
Trotter J,
Schulte R,
Hyman R,
and
Sefton BM.
Changes in the relative abundance of type I and type II lck mRNA transcripts suggest differential promoter usage during T-cell development.
Mol Cell Biol
10:
4266-4270,
1990
36.
Roberts, SJ,
Chung KN,
Nachmanoff K,
and
Elwood PC.
Tissue-specific promoters of the
human folate receptor gene yield transcripts with divergent 5' leader sequences and different translational efficiencies.
Biochem J
326:
439-447,
1997.
37.
Rouault, TA,
Klausner RC,
and
Harford JB.
Translational control of ferritin.
In: Translational Control, edited by Hershey JWB,
Mathews MB,
and Sonenberg N.. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1996, p. 335-362.
38.
Rousseau, D,
Kaspar R,
Rosenwald I,
Gehrke L,
and
Sonenberg N.
Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
Proc Natl Acad Sci USA
93:
1065-1070,
1996
39.
Ruan, H,
Shantz LM,
Pegg AE,
and
Morris DR.
The upstream open reading frame of the mRNA encoding S-adenosylmethionine decarboxylase is a polyamine-responsive translational control element.
J Biol Chem
271:
29576-29582,
1996
40.
Sachs, AB.
Cell cycle-dependent translation initiation: IRES elements prevail.
Cell
101:
243-245,
2000[Web of Science][Medline].
41.
Sachs, AB,
Sarnow P,
and
Hentze MW.
Starting at the beginning, middle, and end: translation initiation in eukaryotes.
Cell
89:
831-838,
1997[Web of Science][Medline].
42.
Shantz, LM,
Hu RH,
and
Pegg AE.
Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
Cancer Res
56:
3265-3269,
1996
43.
Shigaev, A,
Asher C,
Latter H,
Garty H,
and
Reuveny E.
Regulation of sgk by aldosterone and its effects on the epithelial Na+ channel.
Am J Physiol Renal Physiol
278:
F613-F619,
2000
44.
Shimkets, RA,
Lifton R,
and
Canessa CM.
In vivo phosphorylation of the epithelial sodium channel.
Proc Natl Acad Sci USA
95:
3301-3305,
1998
45.
Shimkets, RA,
Warnock DG,
Bositis CM,
Nelson-Williams C,
Hansson JH,
Schambelan M,
Gill JRJ,
Ulick S,
Milora RV,
Findling JW,
Canessa CM,
Rossier BC,
and
Lifton RP.
Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial Na channel.
Cell
79:
404-414,
1994.
46.
Smith, DE,
Otulakowski G,
Yeger H,
Post M,
Cutz E,
and
O'Brodovich HM.
Epithelial Na+ channel (ENaC) expression in the developing normal and abnormal human perinatal lung.
Am J Respir Crit Care Med
161:
1322-1331,
2000
47.
Snyder, PM,
Cheng C,
Prince LS,
Rogers JC,
and
Welsh MJ.
Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits.
J Biol Chem
273:
681-684,
1998
48.
Staub, O,
Gautschi I,
Ishikawa T,
Breitschopf K,
Ciechanover A,
Schild L,
and
Rotin D.
Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination.
EMBO J
16:
6325-6336,
1997[Web of Science][Medline].
49.
Sun, XL,
and
Antony AC.
Evidence that a specific interaction between an 18-base cis-element in the 5'-untranslated region of human folate receptor-
mRNA and a 46-kDa cytosolic trans-factor is critical for translation.
J Biol Chem
271:
25539-25547,
1996
50.
Talbot, CL,
Bosworth DG,
Briley EL,
Fenstermacher DA,
Boucher RC,
Gabriel SE,
and
Barker PM.
Quantitation and localization of ENaC subunit expression in fetal, newborn, and adult mouse lung.
Am J Respir Cell Mol Biol
20:
398-406,
1999
51.
Thomas, CP,
Auerbach S,
Stokes JB,
and
Volk KA.
5' Heterogeneity in epithelial sodium channel
-subunit mRNA leads to distinct NH2-terminal variant proteins.
Am J Physiol Cell Physiol
274:
C1312-C1323,
1998
52.
Valentijn, JA,
Fyfe GK,
and
Canessa CM.
Biosynthesis and processing of epithelial sodium channels in Xenopus oocytes.
J Biol Chem
273:
30344-30351,
1998
53.
Voilley, N,
Galibert A,
Bassilana F,
Renard S,
Lingueglia E,
Coscoy S,
Champigny G,
Hofman P,
Lazdunski M,
and
Barbry P.
The amiloride-sensitive Na+ channel: from primary structure to function.
Comp Biochem Physiol A Physiol
118:
193-200,
1997[Medline].
54.
Waterhouse, P,
Khokha R,
and
Denhardt DT.
Modulation of translation by the 5' leader sequence of the mRNA encoding murine tissue inhibitor of metalloproteinases.
J Biol Chem
265:
5585-5589,
1990
This article has been cited by other articles:
![]() |
A. Dagenais, R. Frechette, M.-E. Clermont, C. Masse, A. Prive, E. Brochiero, and Y. Berthiaume Dexamethasone inhibits the action of TNF on ENaC expression and activity Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1220 - L1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Folkesson and M. A. Matthay Alveolar Epithelial Ion and Fluid Transport: Recent Progress Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 10 - 19. [Full Text] [PDF] |
||||
![]() |
G. Otulakowski, B. Rafii, M. Harris, and H. O'Brodovich Oxygen and Glucocorticoids Modulate {alpha}ENaC mRNA Translation in Fetal Distal Lung Epithelium Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 204 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Otulakowski, B. Rafii, and H. O'Brodovich Differential Translational Efficiency of ENaC Subunits During Lung Development Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 862 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Matthay, H. G. Folkesson, and C. Clerici Lung Epithelial Fluid Transport and the Resolution of Pulmonary Edema Physiol Rev, July 1, 2002; 82(3): 569 - 600. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |